Primary Pulmonary Myxoid Sarcoma: A Rare and Challenging Diagnosis in Thoracic Oncology
Downloads
Introduction: Primary pulmonary myxoid sarcoma (PPMS) is a rare malignant mesenchymal lung tumor, with fewer than 40 cases reported worldwide. This report presents a case of PPMS with surgical difficulties.
Case: A 53-year-old male presented with a six-month history of exertional dyspnea, coughing up blood, right chest pain, anorexia, and weight loss. Thoracic CT imaging revealed an enhancing solid mass in the middle-posterior mediastinum. Histopathological examination of a core biopsy identified anaplastic lipoblast cells indicative of liposarcoma. Based on the multidisciplinary team (MDT) discussion, the patient was diagnosed with mediastinal liposarcoma and tumor excision was planned. However, during the surgery, a lung tumor with adhesions to the middle and lower lobes of the right lung was discovered, precluding complete tumor. An open biopsy was performed instead, revealing a proliferation of anaplastic cells with round to oval spindle nuclei, arranged reticularly within a myxoid stroma, along with positive Alcian blue staining. Immunohistochemical analysis demonstrated focal desmin positivity in the cytoplasm of the tumor cells. The diagnosis of PPMS was confirmed based on the criteria by the World Health Organization (WHO) in 2021, including primary lung tumor, spindle-shaped and round tumor cells in a reticular pattern within a myxoid stroma, and immunohistochemical findings that exclude other histologically similar tumors.
Conclusion: Although rare, PPMS should be considered in the differential diagnosis of thoracic tumors. This case is consistent with findings from previous cases. Most PPMS patients were treated surgically and had a good prognosis. However, tumor excision could not be performed in this patient due to the adhesion of the tumor mass to the middle and lower lobes of the right lung.
Mocellin S. Soft tissue tumors: a practical and comprehensive guide to sarcomas and benign neoplasms. Springer Nature Switzerland AG 2021; 219:691-692. [Book]
Nicholson AG, Baandrup U, Florio R, et al. Malignant myxoid endobronchial tumour: a report of two cases with a unique histological pattern. Histopathology 1999; 35:313-318. [PubMed]
Thway K, Nicholson AG, Lawson K, et al. Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion: a new tumor entity. Am J Surg Pathol 2011; 35:1722-1732. [PubMed]
Nicholson AG, Tsao MS, Beasley MB et al. The 2021 WHO classification of lung tumors: impact of advances since 2015. Journal of Thoracic Oncology 2021; 7(3):362-387. [PubMed]
Wu Y, Luo Y, Gong Y, et al. Primary pulmonary myxoid sarcoma: report of one case and literature review. Int J Clin Exp Pathol 2021; 14(2):230-237. [PubMed]
WHO Classification of Tumours Editorial Board. Thoracic Tumours. 5th ed. Lyon, France: International Agency for Research on Cancer; 2021. [Book]
Chen Z, Yang Y, Chen R, Ng CS and Shi H. Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion: a case report and review of the literature. Diagn Pathol 2020; 15:15. [PubMed]
Smith SC, Palanisamy N, Betz BL, et al. At the intersection of primary pulmonary myxoid sarcoma and pulmonary angiomatoid fibrous histiocytoma: observations from three new cases. Histopathology 2014; 65:144-146. [PubMed]
Agaimy A, Duell T and Morresi-Hauf AT. EWSR1-fusion-negative, SMARCB1-deficient primary pulmonary myxoid sarcoma. Pol J Pathol 2017; 68:261-267. [PubMed]
Prieto-Granada CN, Ganim RB, Zhang L, et al. Primary pulmonary myxoid sarcoma: a newly described entity-report of a case and review of the literature. Int J Surg Pathol 2017; 25:518-525. [PubMed]
Yanagida R, Balzer BL, McKenna RJ, et al. Primary pulmonary myxoid sarcoma, a potential mimic of metastatic extraskeletal myxoid chondrosarcoma. Pathology 2017; 49:792-794. [PubMed]
Smith SC, Palanisamy N, Betz BL, et al. At the intersection of primary pulmonary myxoid sarcoma and pulmonary angiomatoid fibrous histiocytoma: observations from three new cases. Histopathology 2014; 65:144-146.
Gui H, Sussman RT, Jian B, et al. Primary pulmonary myxoid sarcoma and myxoid angiomatoid fibrous histiocytoma a unifying continuum with shared and distinct features. The American Journal of Surgical Pathology 2020; 44(11):1535-1540. [PubMed]
Kerper AL, Larsen BT, Folpe AL, et al. Primary pulmonary myxoid sarcoma and thoracic angiomatoid fibrous histiocytoma: two sides of the same coin? Am J Surg Pathol 2024; 48(5):562-569. [PubMed]
Nishina M, Harada H, Kamigaichi A, et al. Primary pulmonary myxoid sarcoma with ewsr1 rearrangement: a case report. Journal of Thoracic Oncology 2021; Volume 16, Issue 3, S377. [ScienceDirect]
Halpern AI, Behtaj M, Arbzadeh E, et al. Primary pulmonary myxoid sarcoma in an asymptomatic 47-year-old female. J. Respir 2024; 4(3):158-162. [Journal]
Xu T, Wu L, Ye H, et al. Primary pulmonary myxoid sarcoma in the interlobar fissure of the left lung lobe: a case report. BMC Pulmonary Medicine 2024; 24:313. [PubMed]
Miao X, Chen J, Yang L, et al. Primary pulmonary myxoid sarcoma with EWSR1::CREB1 fusion: a literature review. J Cancer Res Clin Oncol 2024; 150:108. [PubMed]
Nishimura T, Ii T, Inamori O, et al. Primary pulmonary myxoid sarcoma with EWSR1::ATF1 fusion: a case report. International Journal of Surgical Pathology 2023; 31(1):88-91. [PubMed]
Kim S, Song SY, Yun JS, et al. Primary pulmonary myxoid sarcoma located in interlobar fissure without parenchymal invasion. Thoracic Cancer 2017; 8:535-538. [PubMed]
Copyright (c) 2025 Yudi Apriyanto, Anna Febriani, Laksmi Wulandari, Farah Fatma Wati
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution Share-Alike (CC BY-SA).
4. The Creative Commons Attribution Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under "the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violation.